Biogen Inc (BIIB)

280.39 +0.18  +0.06% NASDAQ May 17, 16:59 USD
View Full Chart
Price Chart
View All BIIB News

News

View All Events

Events

Date Type Description
07/22/2021 00:00 Earnings Results Q2 2021 Earnings Results
07/22/2021 08:00 Earnings Calls Q2 2021 Earnings Call
04/22/2021 00:00 Earnings Results Q1 2021 Earnings Results
04/22/2021 08:00 EDT Earnings Calls Q1 2021 Earnings Call
02/03/2021 00:00 Earnings Results Q4 2020 Earnings Results
02/03/2021 08:00 EST Earnings Calls Q4 2020 Earnings Call
10/21/2020 00:00 Earnings Results Q3 2020 Earnings Results
10/21/2020 08:00 EDT Earnings Calls Q3 2020 Earnings Call
07/22/2020 08:00 EDT Earnings Calls Q2 2020 Earnings Call
07/22/2020 00:00 Earnings Results Q2 2020 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva are marketed via a collaboration with Roche. Biogen also markets novel MS drugs Plegridy, Tysabri, Tecfidera, and Vumerity. In Japan, Biogen's MS portfolio is co-promoted by Eisai. Hemophilia therapies Eloctate and Alprolix (partnered with SOBI) were spun off as part of Bioverativ in 2017. Biogen has several drug candidates in phase 3 trials in neurology and neurodegenerative diseases and has launched Spinraza with partner Ionis.
  • URL: http://www.biogen.com
  • Investor Relations URL: https://www.biogen.com/en_us/investors.html
  • HQ State/Province: Massachusetts
  • Sector: Healthcare
  • Industry: Drug Manufacturers - General
  • Equity Style: Large Cap/Value
  • Next Earnings Release: Jul. 22, 2021
  • Last Earnings Release: Apr. 22, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Top Fund Holders

Symbol Name Weighting
LMPFX ClearBridge Aggressive Growth FI 5.95%
PKW Invesco BuyBack Achievers ETF 4.67%
FBIOX Fidelity® Select Biotechnology 4.03%
VPMCX Vanguard PRIMECAP Inv 3.68%
IBB iShares Nasdaq Biotechnology ETF 3.63%
FBT First Trust NYSE Arca Biotech ETF 3.45%
VPCCX Vanguard PRIMECAP Core Inv 2.95%
VHCOX Vanguard Capital Opportunity Inv 2.92%
HQH Tekla Healthcare Investors 2.79%
MOAT VanEck Vectors Morningstar Wide Moat ETF 2.49%
VGHCX Vanguard Health Care Inv 2.48%
XBI SPDR® S&P Biotech ETF 0.77%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.